Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuromuscular
•
Pain Medicine
When would you consider testing for LGI1 antibodies in patients with unexplained neuropathic pain?
Related Questions
When do you recommend scrambler therapy for chronic neuropathic pain?
How do you counsel patients and doctors on antibiotic avoidance in myasthenia gravis?
When do you consider testing autoimmune antibodies for axonal polyneuropathies without clear etiology?
Would you add immunosuppression in ocular myasthenia gravis patients who are symptomatically well-controlled on pyridostigmine?
What do you consider when there is incidentally found patchy peripheral nerve enlargement on imaging with otherwise unremarkable clinical and electrophysiological findings?
When would you refer patients with Parsonage-Turner syndrome for surgical treatment?
What treatments, after appropriate dose reductions/delays, do you offer for patients with oxaliplatin-induced cold allodynia/dysesthesia?
How do you counsel patients on the benefits of immunotherapy for anti-MAG neuropathy?
What is your approach to patients with diffuse, patchy paresthesias affecting the head, face, lips, and/or tongue?
How do you navigate C-2 refills in patients who are stable in their treatment and do not otherwise need to be clinically seen monthly?
